BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CYP51
,
Response to oxidative stress
,
Diabetes mellitus
,
Lung
,
Laryngoscope
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAGE proteins
Summary
General Info
Curated Studies
Most Correlated Studies
Cord blood hematopoietic progenitor cells differentiated by growth factors and treated with TGFbeta
Effect of SOCS3 on the transcriptional response of bone marrow-derived macrophages to IL-6
Systemic lupus erythematosus in rabbit models induced by peptide immunization
T follicular helper OT-II cells after immune challenge and anti-ICOS-L blockade
Control of LPS-response by DUSP1
Explore Curated Studies Results
Literature
Most Relevant Literature
Functional interaction between co-expressed MAGE-A proteins.
The MAGE protein family and cancer.
MAGE-I proteins and cancer-pathways: A bidirectional relationship.
Expression and Clinical Significance of MAGE-A Proteins and mRNA in Lung Cancer Patients: A Retrospe…
GK-1 improves the immune response induced by bone marrow dendritic cells loaded with MAGE-AX in mice…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cel…
Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MA…
ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers…
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ